Class Action Complaint Says Nasal Decongestant Makers Misrepresented Efficacy



DOCUMENTS
  • Complaint


PENSACOLA, Fla. — A Florida man has filed a federal class action against Procter & Gamble and Johnson & Johnson Consumer Inc., alleging the active ingredient, phenylephrine, in their popular over-the-counter oral nasal decongestants did not work as advertised.

The Sept. 13 complaint filed in the U.S. District Court for the Northern District of Florida seeks refunds on behalf of two groups of consumers who he says suffered economic damages after buying Sudafed PE, Vicks NyQuil, and Benadryl Allergy Plus Congestion.

Steve Audelo filed the complaint after a Food and Drug Administration panel stated that phenylephrine, when taken orally, …






UPCOMING CONFERENCES




HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference

January 10, 2025 - Long Beach, CA
The Westin Long Beach

MORE DETAILS



HarrisMartin's New Jersey Asbestos Litigation Conference

February 27, 2025 - New Brunswick, NJ
Hyatt Regency New Brunswick

MORE DETAILS